Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00873366 · ClinicalTrials.gov registry record
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 92
- Enrollment target
NCT00873366: Clinical Trial study, sponsored by Mayo Clinic.
NCT00873366 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00873366 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 92 participants
- Enrollment target
Study Summary
RATIONALE: A breath test that measures enzymes may be effective in identifying women in whom tamoxifen may not be effective. PURPOSE: This clinical trial is studying a breath test to see how well it works in women receiving tamoxifen for the prevention or treatment of breast cancer.
Interventions
- OTHER laboratory biomarker analysis
- OTHER pharmacogenomic studies
- DRUG tamoxifen citrate
- OTHER high performance liquid chromatography
- DRUG dextromethorphan hydrobromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2009-05 |
| Est. Completion | 2015-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00873366
The ClinicalTrials.gov registry entry for NCT00873366 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT00873366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00873366 about?
NCT00873366 is a clinical study titled "Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer". RATIONALE: A breath test that measures enzymes may be effective in identifying women in whom tamoxifen may not be effective. PURPOSE: This clinical trial is studying a breath test to see how well it works in women receiving tamoxifen for the prevention or treatment of breast cancer.
What is the current status of trial NCT00873366?
This trial is currently terminated. The enrollment target is 92 participants. The study started on 2009-05. Estimated completion is 2015-09-23.
What interventions are being tested in trial NCT00873366?
The interventions under investigation include: laboratory biomarker analysis (OTHER), pharmacogenomic studies (OTHER), tamoxifen citrate (DRUG), high performance liquid chromatography (OTHER), dextromethorphan hydrobromide (DRUG).
Who is sponsoring clinical trial NCT00873366?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.